Calidi Biotherapeutics Inc (CLDI)
0.2304
-0.01
(-4.79%)
USD |
NYAM |
May 17, 16:00
0.2304
0.00 (0.00%)
After-Hours: 16:09
Calidi Biotherapeutics Cash from Financing (Quarterly)
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2023 | 32.00M |
| September 30, 2022 | 7.768M |
| Date | Value |
|---|---|
| September 30, 2021 | 8.318M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
7.768M
Minimum
Sep 2022
32.00M
Maximum
Sep 2023
16.03M
Average
8.318M
Median
Sep 2021
Cash from Financing (Quarterly) Benchmarks
| Minerva Neurosciences Inc | 0.00 |
| Viking Therapeutics Inc | 606.04M |
| CytomX Therapeutics Inc | 0.174M |
| Genprex Inc | 0.00 |
| Janux Therapeutics Inc | 322.17M |